MINIject Global Long-Term Follow-up Study

Launched by ISTAR MEDICAL · Aug 20, 2020

Keywords

ClinConnect Summary

The MINIject Global Long-Term Follow-up Study is a clinical trial that looks at the long-term safety and effectiveness of a device called the MINIject glaucoma implant. This study focuses on patients who have open-angle glaucoma or ocular hypertension and have not been able to control their condition with standard eye drops. The trial aims to follow these patients for up to 5 years to see how well the implant works over time.

To participate, patients must have already received the MINIject implant in a previous study and still have it in place. They also need to agree to take part by signing a consent form. People who are under legal guardianship or who cannot attend the necessary study visits will not be eligible. Participants can expect regular check-ups and assessments throughout the study period, helping researchers understand the long-term effects of this treatment. This study is currently recruiting participants aged 18 and older, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient who received a MINIject glaucoma implant within a prior clinical study
• • Patient continues to have MINIject implanted at the point of enrolment
• • Patient must provide written informed consent to participate
• Exclusion Criteria:
• • Individuals under tutorship or trusteeship
• • Patient who is unwilling to return to the study visits and undergo study assessments, as required by clinical study protocol